ChromaDex Shares Jump on Tru Niagen's Launch In Walmart Stores

To add Benzinga News as your preferred source on Google, click here.

ChromaDex Corp (NASDAQ:CDXC) has launched its flagship consumer product Tru Niagen in Walmart Inc (NYSE:WMT), available in 3,800 stores across the U.S.
The NAD+ booster will be offered to Walmart customers in two distinct serving sizes, 100mg and 300mg.
Tru Niagen is a form of vitamin B3 clinically proven to elevate NAD+, reducing the impact of aging and daily wear and tear on the body.
NAD+ is a vital coenzyme naturally produced in the body, and studies have shown NAD+ declines up to 50% between the ages of 40 and 60.
Based on a 300mg/day serving, Tru Niagen can increase NAD+ by 40-50%.
Related content: ChromaDex CEO Rings Nasdaq Closing Bell, Talks Walmart Product Launch.
Price Action: CDXC shares are up 11.7% at $9.99 during the market session on the last check Monday.

To add Benzinga News as your preferred source on Google, click here.